Omnisystem Co.,Ltd. (KOSDAQ:057540)
806.00
-2.00 (-0.25%)
At close: Jun 30, 2026
Omnisystem Revenue
Omnisystem had revenue of 18.36B KRW in the quarter ending March 31, 2026, a decrease of -32.57%. This brings the company's revenue in the last twelve months to 90.20B, down -20.42% year-over-year. In the year 2025, Omnisystem had annual revenue of 99.07B, down -9.19%.
Revenue (ttm)
90.20B
Revenue Growth
-20.42%
P/S Ratio
0.53
Revenue / Employee
843.00M
Employees
107
Market Cap
47.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 99.07B | -10.02B | -9.19% |
| Dec 31, 2024 | 109.09B | 17.66B | 19.32% |
| Dec 31, 2023 | 91.43B | -6.62B | -6.75% |
| Dec 31, 2022 | 98.05B | 6.95B | 7.63% |
| Dec 31, 2021 | 91.10B | -7.20B | -7.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guyoung Technology | 470.49B |
| CAP Co.,Ltd. | 290.15B |
| Heerim Architects & Planners | 234.24B |
| Jin Yang Pharmaceutical | 122.15B |
| Daewon | 104.52B |
| Obigo | 40.36B |
| POINT ENGINEERING | 33.37B |
| Russell | 30.53B |